نتائج البحث 291-300 من 2282 لعملية البحث عن GLP-1 agonists
The purpose of this study is to determine the effectiveness of MB-CART2019.1 cells administered following a conditioning lymphodepletion regimen in diffuse ...
Patients will be randomized 1:1 into the two arms. Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will ...
Patients will be randomized in a 1:1 ... Patients will be randomized 1:1 into the two arms. ... Avelumab In Combination Regimens That Include An Immune Agonist ...
... 1 monotherapy dose finding and a part 2 (cohort expansion in two cohorts). Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn ...
Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study is ...
ENPP1 variants associated with autosomal recessive hypophosphatemic rickets type 2 A case from the endocrine teaching clinics · عطاؤك له أثر كبير — تبرَّع الآن!
The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
... Agonist Therapy. Rochester, Minn ... agonists (DA), to determine the predictors of ICD ... توجّه للصفحة 11 · توجّه للصفحة 22 · توجّه للصفحة 33 ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.